Context: SARS CoV 2 induced cytokine storm is the major cause of COVID 19 related
deaths. Patients have been treated with drugs that work by inhibiting a specific protein partly …

Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) induced cytokine storm is
the major cause of COVID-19 related deaths. Patients have been treated with drugs that …

Background Drug repurposing is a fast and effective way to develop drugs for an emerging
disease such as COVID-19. The main challenges of effective drug repurposing are the …

Objective The repurposing of nitazoxanide, doxycycline and azithromycin may be effective to
improve the symptoms in mild and moderate COVID‐19 subjects. This study aimed to detect …

In COVID-19, patients in severe condition often suffer from a major complication that leads to
lung injury, ARDS and possibly death: the cytokine storm. The cytokine storm is composed of …

Introduction: Repurposing existing drugs approved for other conditions is crucial to
identifying specific therapeutics against SARS-CoV-2 (severe acute respiratory syndrome …

The COVID-19 was described as a respiratory illness, however further studies recognize it
as a complex heterogeneous multisystemic disorder. Global efforts have been proposed to …

A molecule of dimension 125nm has caused around 479 Million human infections (80M for
the USA) & 6.1 Million human deaths (977,000 for the USA) worldwide and slashed the …

Abstract The SARS-CoV-2 pandemic (COVID-19) created an urgency to find a potential drug
molecule for its cure. Repurposing of FDA-approved drugs facilitated by preliminary …

Abstract Although 15–20% of COVID‐19 patients experience hyper‐inflammation induced
by massive cytokine production, cellular triggers of this process and strategies to target them …